Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Dose-response and time-response study of erythrocytosis in rats after intrarenal injection of nickel subsulfide

Journal Article · · Ann. Clin. Lab. Sci.; (United States)
OSTI ID:7287113
Erythrocytosis was induced in Fischer rats by intrarenal (ir) injection of nickel subsulfide (Ni/sub 3/S/sub 2/) in dosages ranging from 0.6 to 10 mg per rat. Measurements of blood packed cell volume (PCV) became increased by one month after ir injection of Ni/sub 3/S/sub 2/; reached maximum values at approximately two months; and gradually returned to control values by seven months. The duration and magnitude of erythrocytosis were related to the dosage of Ni/sub 3/S/sub 2/. Increases in hemoglobin concentrations and erythrocyte counts (RBC) in Ni/sub 3/S/sub 2/-treated rats were consistently proportional to blood PCV values. Blood hemoglobin concentration was 24.9 +- 1.2 g per dl at two months after bilateral ir injection of Ni/sub 3/S/sub 2/ (10 mg per rat), versus 15.8 +- 0.5 g per dl in saline-injected controls (P less than 0.001). No significant changes occurred in leukocyte or platelet counts of Ni/sub 3/S/sub 2/-treated rats. Autopsy of rats killed two months after ir injection of Ni/sub 3/S/sub 2/ showed marked erythroid hyperplasia of bone marrow and fibrotic needle tracts in renal parenchyma with localized deposits of particles of Ni/sub 3/S/sub 2/. In contrast to the erythrocytosis induced by ir injection of Ni/sub 3/S/sub 2/, administration of Ni/sub 3/S/sub 2/ by intramuscular (im) injection (10 mg per rat) had no significant effect upon blood PCV, RBC or hemoglobin values or upon morphology of bone marrow.
Research Organization:
Univ. of Connecticut School of Medicine, Farmington
OSTI ID:
7287113
Journal Information:
Ann. Clin. Lab. Sci.; (United States), Journal Name: Ann. Clin. Lab. Sci.; (United States) Vol. 7:1; ISSN ACLSC
Country of Publication:
United States
Language:
English